Hear why you should submit your abstract in this video from EB 2018.
Abstract Deadline
Abstract submissions are closed.
Notifications about acceptance of abstracts submitted by November 18th, will be sent in early February. Notifications about acceptance of Late-Breaking abstracts will be sent in early March.
Submit your research to an ASPET topic category
How to be considered for ASPET Oral Presentations
Abstracts submitted by November 18th by students and postdocs may also be considered for an oral presentation in related symposia, division platform sessions, or the ASPET Daily Datablitz session. If selected for oral presentation, you will also be scheduled to present
a poster in the EB exhibit/poster hall.
How to be considered for an ASPET Travel Award
Eligible students and postdocs must submit their work through EB to any ASPET category below AND complete the related ASPET application forms. Applications for ASPET travel
awards close on Sunday, November 18, 2018.
How to be considered for an ASPET Poster Award
Eligible students and postdocs must submit their work through EB to any ASPET category below AND complete the related ASPET application forms. Applications for ASPET
poster awards close on Sunday, November 18, 2018.
Criteria for Abstract Acceptance
Abstracts submitted for consideration will be reviewed by the ASPET Program Committee. For acceptance for presentation and publication, abstracts must comply with the instructions and scientific integrity policy as outlined by the Experimental Biology meeting as well as meet the ASPET criteria below:
- Scientific Merit (original concept, improvement of previous idea, expands the field)
- Technical Quality (there are no major design or analysis issues)
- Abstract is Complete (contains a clear and satisfactory Objective/Aim/Hypothesis, Design/Approach/Methods, Results, and Conclusion)
- Relevance (contributes to improvement in scientific understanding)
- Originality (no concerns about scientific integrity/plagiarism)
- Language (satisfactory grammar/style and organization)
There is no guarantee that one’s abstract will be accepted or published.
Topic Categories
Late-Breaking Abstract Topics |
300-ASPET | Cancer Pharmacology |
301-ASPET | Cardiovascular Pharmacology (CVP) |
302-ASPET | Cellular and Molecular Pharmacology
|
303-ASPET | Central Nervous System Pharmacology
|
304-ASPET | Drug Discovery and Development
|
305-ASPET | Drug Metabolism and Disposition (DVD)
|
306-ASPET | Pharmacogenomics and Translational Pharmacology
|
307-ASPET | Pharmacology Education
|
308-ASPET | Toxicology
|
309-ASPET | Pharmacology – Other
|
Cancer Pharmacology |
3000-ASPET | Cancer Models |
3001-ASPET | Drug Targets in Cancer |
3002-ASPET | Anticancer Drug Response |
3003-ASPET | Cancer Cell Signaling |
3004-ASPET | Cancer Immunotherapy |
Cardiovascular Pharmacology (CVP) |
3005-ASPET | Cardiovascular Pharmacology |
3006-ASPET | Vascular Pharmacology |
3007-ASPET | Cardiac Pharmacology |
3008-ASPET | Renal Pharmacology |
3009-ASPET | Hypertension |
3010-ASPET | Diabetes and Cardiovascular Disease |
Cellular and Molecular Pharmacology |
3011-ASPET | Gene Expression/Regulation |
3012-ASPET | Omics / Big Data |
3013-ASPET | Signal Transduction - General |
3014-ASPET | Signal Transduction - G Proteins/GPCRs |
3015-ASPET | Signal Transduction - Ion Channels |
3016-ASPET | Signal Transduction - Kinases/Phosphatases/RTKs |
3017-ASPET | Signal Transduction - Second Messenger Systems |
3018-ASPET | Signal Transduction - Other Receptors |
3019-ASPET | Mechanisms of Cell Injury/Death |
3020-ASPET | Oxidative Stress |
3021-ASPET | Mitochondrial Pharmacology & Toxicology |
Central Nervous System Pharmacology |
3022-ASPET | Behavioral Pharmacology |
3023-ASPET | Drugs of Abuse and Addiction |
3024-ASPET | Neuropharmacology |
3025-ASPET | Biogenic Amines |
3026-ASPET | CNS Transporters and Channels |
3027-ASPET | Neuropharmacology Postdoc Showcase |
Drug Discovery and Development |
3028-ASPET | Drug Discovery and Development |
Drug Metabolism and Disposition (DMD) |
3029-ASPET | DMD - General |
3030-ASPET | DMD - Pharmacokinetics/Modeling |
3031-ASPET | DMD - Metabolic Enzymes |
3032-ASPET | DMD - Transporters |
3033-ASPET | DMD - Transcription Regulation |
Pharmacogenomics and Translational Pharmacology |
3034-ASPET | Translational Research |
3035-ASPET | Clinical Pharmacology |
3036-ASPET | Preclinical Pharmacology |
3037-ASPET | Metabolic Pharmacology |
3038-ASPET | Quantitative Systems / Precision Medicine |
3039-ASPET | Regenerative Pharmacology |
3040-ASPET | GI Pharmacology |
3041-ASPET | Translational and Clinical Pharmacology Trainee Showcase |
Pharmacology Education |
3042-ASPET | Pharmacology Education |
Toxicology |
3043-ASPET | Biochemical/Mechanistic Toxicology |
3044-ASPET | Organ Toxicology |
3045-ASPET | Neurotoxicology |
3046-ASPET | In Vitro Toxicology |
3047-ASPET | Inflammation and Tissue Injury |
3048-ASPET | Natural Products |
Pharmacology - Other |
3049-ASPET | Pharmacology - Microbiome |
3050-ASPET | Pharmacology - All Other |